These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27420606)

  • 1. Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study.
    Schrepf A; Harper DE; Harte SE; Wang H; Ichesco E; Hampson JP; Zubieta JK; Clauw DJ; Harris RE
    Pain; 2016 Oct; 157(10):2217-2225. PubMed ID: 27420606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased central mu-opioid receptor availability in fibromyalgia.
    Harris RE; Clauw DJ; Scott DJ; McLean SA; Gracely RH; Zubieta JK
    J Neurosci; 2007 Sep; 27(37):10000-6. PubMed ID: 17855614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs).
    Harris RE; Zubieta JK; Scott DJ; Napadow V; Gracely RH; Clauw DJ
    Neuroimage; 2009 Sep; 47(3):1077-85. PubMed ID: 19501658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving.
    Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino M; Endres CJ; Dannals RF; Frost JJ
    Biol Psychiatry; 2005 Jun; 57(12):1573-82. PubMed ID: 15953495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociable Roles of Cerebral μ-Opioid and Type 2 Dopamine Receptors in Vicarious Pain: A Combined PET-fMRI Study.
    Karjalainen T; Karlsson HK; Lahnakoski JM; Glerean E; Nuutila P; Jääskeläinen IP; Hari R; Sams M; Nummenmaa L
    Cereb Cortex; 2017 Aug; 27(8):4257-4266. PubMed ID: 28541428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder.
    Hsu DT; Sanford BJ; Meyers KK; Love TM; Hazlett KE; Walker SJ; Mickey BJ; Koeppe RA; Langenecker SA; Zubieta JK
    Mol Psychiatry; 2015 Feb; 20(2):193-200. PubMed ID: 25600108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low- and high-frequency transcutaneous electrical acupoint stimulation induces different effects on cerebral μ-opioid receptor availability in rhesus monkeys.
    Xiang XH; Chen YM; Zhang JM; Tian JH; Han JS; Cui CL
    J Neurosci Res; 2014 May; 92(5):555-63. PubMed ID: 24482187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperament trait Harm Avoidance associates with μ-opioid receptor availability in frontal cortex: a PET study using [(11)C]carfentanil.
    Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Raitakari O; Keltikangas-Järvinen L; Hietala J
    Neuroimage; 2012 Jul; 61(3):670-6. PubMed ID: 22484309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of the μ-opioid receptor gene influence cerebral pain processing in fibromyalgia.
    Ellerbrock I; Sandström A; Tour J; Kadetoff D; Schalling M; Jensen KB; Kosek E
    Eur J Pain; 2021 Feb; 25(2):398-414. PubMed ID: 33064887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo effects on human mu-opioid activity during pain.
    Wager TD; Scott DJ; Zubieta JK
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11056-61. PubMed ID: 17578917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.
    Nuechterlein EB; Ni L; Domino EF; Zubieta JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems.
    Tuominen L; Nummenmaa L; Keltikangas-Järvinen L; Raitakari O; Hietala J
    Hum Brain Mapp; 2014 May; 35(5):1875-84. PubMed ID: 23671038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids.
    Lamusuo S; Hirvonen J; Lindholm P; Martikainen IK; Hagelberg N; Parkkola R; Taiminen T; Hietala J; Helin S; Virtanen A; Pertovaara A; Jääskeläinen SK
    Eur J Pain; 2017 Oct; 21(9):1505-1515. PubMed ID: 28493519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a neurophysiological signature for fibromyalgia.
    López-Solà M; Woo CW; Pujol J; Deus J; Harrison BJ; Monfort J; Wager TD
    Pain; 2017 Jan; 158(1):34-47. PubMed ID: 27583567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system.
    Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF
    Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Building up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary report.
    DosSantos MF; Martikainen IK; Nascimento TD; Love TM; DeBoer MD; Schambra HM; Bikson M; Zubieta JK; DaSilva AF
    PLoS One; 2014; 9(7):e102350. PubMed ID: 25029273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET).
    Bencherif B; Fuchs PN; Sheth R; Dannals RF; Campbell JN; Frost JJ
    Pain; 2002 Oct; 99(3):589-598. PubMed ID: 12406535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of MOR-Positive B Cell as Possible Innovative Biomarker (Mu Lympho-Marker) for Chronic Pain Diagnosis in Patients with Fibromyalgia and Osteoarthritis Diseases.
    Raffaeli W; Malafoglia V; Bonci A; Tenti M; Ilari S; Gremigni P; Iannuccelli C; Gioia C; Di Franco M; Mollace V; Vitiello L; Tomino C; Muscoli C
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. individual variation in sleep quality and duration is related to cerebral mu opioid receptor binding potential during tonic laboratory pain in healthy subjects.
    Campbell CM; Bounds SC; Kuwabara H; Edwards RR; Campbell JN; Haythornthwaite JA; Smith MT
    Pain Med; 2013 Dec; 14(12):1882-92. PubMed ID: 24102962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.
    Weerts EM; Wand GS; Kuwabara H; Munro CA; Dannals RF; Hilton J; Frost JJ; McCaul ME
    Alcohol Clin Exp Res; 2011 Dec; 35(12):2162-73. PubMed ID: 21689118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.